Antiseptic [EPC]

Antiseptic [EPC] was reported 4368 times

Drugs of the Antiseptic [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 AQUEOUS FIBRIN 29 0.5686
1 CSF SHUNT REMOVAL 3 0.3750
2 TOXIC ANTERIOR SEGMENT SYNDROME 287 0.2631
3 HEPATIC ENZYME 34 0.2282
4 ANTERIOR CHAMBER FIBRIN 24 0.1860
5 POLYGLANDULAR DISORDER 11 0.1618
6 TONSILLAR ULCER 23 0.1586
7 FIBRIN 6 0.1395
8 BACTERIAL ENDOPHTHALMITIS 33 0.1241
9 HYPOPYON 85 0.1027
10 FOETAL NON-STRESS TEST ABNORMAL 6 0.1000
11 PAROPHTHALMIA 20 0.0840
12 PSEUDOENDOPHTHALMITIS 8 0.0808
13 ANTERIOR CHAMBER CELL 54 0.0756
14 ENDOPHTHALMITIS 433 0.0721
15 ANAEMIA FOLATE DEFICIENCY 11 0.0570
16 RETINAL FIBROSIS 4 0.0556
17 RETINAL CYST 9 0.0542
18 EYE INFECTION INTRAOCULAR 4 0.0513
19 IODINE ALLERGY 17 0.0511
20 DELAYED DELIVERY 7 0.0493
21 ANTERIOR CHAMBER DISORDER 11 0.0478
22 BALANITIS CANDIDA 6 0.0469
23 LOWER RESPIRATORY TRACT INFECTION VIRAL 23 0.0455
24 OPHTHALMOLOGICAL EXAMINATION ABNORMAL 8 0.0452
25 TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 8 0.0442
26 NON-INFECTIOUS ENDOPHTHALMITIS 35 0.0412
27 CANDIDA ENDOPHTHALMITIS 5 0.0410
28 VITREAL CELLS 8 0.0396
29 CORNEAL INFILTRATES 12 0.0382
30 RETINOPATHY OF PREMATURITY 21 0.0379
31 VITRITIS 69 0.0372
32 VITREOUS DEGENERATION 6 0.0366
33 POSTOPERATIVE INFECTION 17 0.0359
34 CORNEAL OEDEMA 79 0.0352
35 RETINAL ANEURYSM 7 0.0350
36 CUTIS LAXA 9 0.0331
37 CORNEAL EPITHELIUM DEFECT 19 0.0327
38 VITREOUS HAZE 5 0.0327
39 CATARACT NUCLEAR 21 0.0315
40 RETINAL DRUSEN 5 0.0305
41 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 11 0.0303
42 RETINOGRAM ABNORMAL 8 0.0299
43 CATARACT OPERATION COMPLICATION 15 0.0295
44 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 25 0.0281
45 EYE NAEVUS 3 0.0263
46 PUNCTATE KERATITIS 24 0.0261
47 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 32 0.0257
48 CONJUNCTIVAL OEDEMA 26 0.0253
49 IRIS ATROPHY 5 0.0242
50 RETINAL SCAR 11 0.0239
51 ANTERIOR CHAMBER INFLAMMATION 14 0.0235
52 HYPOCHOLESTEROLAEMIA 8 0.0227
53 ONYCHOMADESIS 95 0.0226
54 BILE ACIDS INCREASED 4 0.0226
55 FLAT ANTERIOR CHAMBER OF EYE 4 0.0223
56 RETINAL OCCLUSIVE VASCULITIS 5 0.0223
57 NAIL BED INFLAMMATION 7 0.0219
58 RHEUMATIC FEVER 97 0.0217
59 RETINAL PIGMENT EPITHELIAL TEAR 15 0.0216
60 ANTERIOR CHAMBER FLARE 5 0.0215
61 DISORDER OF ORBIT 3 0.0208
62 VITREOUS DISORDER 10 0.0207
63 MACULAR SCAR 4 0.0206
64 SUBRETINAL FIBROSIS 4 0.0205
65 CATARACT CORTICAL 3 0.0201
66 LIP ULCERATION 23 0.0197
67 VISUAL ACUITY REDUCED TRANSIENTLY 6 0.0195
68 CORNEAL DECOMPENSATION 3 0.0186
69 EYE OPERATION COMPLICATION 3 0.0183
70 CORNEAL ABRASION 25 0.0182
71 ONYCHOMYCOSIS 78 0.0178
72 DIABETIC RETINAL OEDEMA 9 0.0177
73 MACULAR FIBROSIS 11 0.0162
74 POSTERIOR CAPSULE OPACIFICATION 5 0.0146
75 FACET JOINT SYNDROME 47 0.0144
76 EPIRETINAL MEMBRANE 4 0.0144
77 HYPOPARATHYROIDISM 11 0.0143
78 HYPOTONY OF EYE 6 0.0143
79 VITREOUS OPACITIES 12 0.0142
80 INTRAOCULAR LENS IMPLANT 7 0.0141
81 CORNEAL INFECTION 3 0.0138
82 CHRONIC HEPATITIS 11 0.0136
83 HYPHAEMA 7 0.0134
84 SKIN CANDIDA 7 0.0134
85 VITREOUS DETACHMENT 29 0.0134
86 CORNEAL OPACITY 18 0.0132
87 METAMORPHOPSIA 24 0.0130
88 CAUSTIC INJURY 4 0.0128
89 EYE INFECTION BACTERIAL 7 0.0125
90 VITREOUS HAEMORRHAGE 34 0.0123
91 MATERNAL EXPOSURE DURING DELIVERY 12 0.0121
92 RETINAL EXUDATES 11 0.0118
93 CHOROIDAL NEOVASCULARISATION 10 0.0117
94 DENTURE WEARER 3 0.0116
95 C-REACTIVE PROTEIN ABNORMAL 73 0.0114
96 ENTEROCUTANEOUS FISTULA 10 0.0113
97 PERIPHERAL VENOUS DISEASE 46 0.0113
98 OCULAR TOXICITY 12 0.0109
99 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 6 0.0107
100 PEMPHIGUS 132 0.0105
101 BURNS FIRST DEGREE 3 0.0105
102 EYE INFECTION STAPHYLOCOCCAL 3 0.0104
103 RETINAL INJURY 8 0.0104
104 NASAL MUCOSAL DISORDER 6 0.0103
105 VASOCONSTRICTION 9 0.0103
106 ECTHYMA 4 0.0100
107 RETINAL OEDEMA 19 0.0099
108 BLEPHAROSPASM 62 0.0098
109 EYE ABSCESS 3 0.0098
110 OCULAR HYPERTENSION 18 0.0093
111 PRODUCT CONTAMINATION MICROBIAL 11 0.0092
112 LENTICULAR OPACITIES 4 0.0092
113 DUODENAL ULCER PERFORATION 67 0.0090
114 EXOPHTHALMOS 19 0.0088
115 LUPUS VULGARIS 11 0.0087
116 ENDOCRINE DISORDER 11 0.0086
117 EYE OEDEMA 21 0.0086
118 RETINAL VASCULAR DISORDER 5 0.0085
119 TONGUE ERYTHEMA 7 0.0085
120 BREAST CANCER STAGE III 55 0.0085
121 CYSTOID MACULAR OEDEMA 16 0.0085
122 KERATIC PRECIPITATES 4 0.0084
123 CATHETER REMOVAL 3 0.0084
124 EYE SYMPTOM 3 0.0084
125 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 60 0.0084
126 PERICARDITIS 140 0.0083
127 RETINAL ISCHAEMIA 5 0.0082
128 OPEN ANGLE GLAUCOMA 5 0.0081
129 POST PROCEDURAL DISCOMFORT 17 0.0081
130 GLARE 4 0.0078
131 IRIS ADHESIONS 4 0.0078
132 OLIGURIA 48 0.0077
133 MACULAR OEDEMA 43 0.0077
134 VITREOUS FLOATERS 75 0.0076
135 FOLLICULITIS 79 0.0075
136 DEEP VEIN THROMBOSIS POSTOPERATIVE 15 0.0075
137 CORNEAL EROSION 4 0.0074
138 RETINAL DISORDER 19 0.0073
139 EYE INFLAMMATION 69 0.0072
140 PRESBYOPIA 4 0.0072
141 CULTURE POSITIVE 6 0.0072
142 NAIL DYSTROPHY 4 0.0071
143 OVERLAP SYNDROME 5 0.0071
144 TWIN PREGNANCY 6 0.0071
145 IRIDOCYCLITIS 22 0.0070
146 RETINITIS 12 0.0069
147 CHEMICAL BURN 8 0.0069
148 CELLULITIS ORBITAL 4 0.0069
149 EYELID INFECTION 3 0.0068
150 BRAIN STEM SYNDROME 5 0.0067
151 BANKRUPTCY 3 0.0067
152 SYNOVITIS 120 0.0066
153 ALLERGY TEST POSITIVE 3 0.0066
154 RETINAL HAEMORRHAGE 47 0.0066
155 CATARACT SUBCAPSULAR 4 0.0066
156 MUSCLE INJURY 54 0.0065
157 CAUDA EQUINA SYNDROME 5 0.0065
158 STRESS URINARY INCONTINENCE 7 0.0065
159 SKIN TEST POSITIVE 6 0.0064
160 HYPERCHOLESTEROLAEMIA 61 0.0063
161 LIP DRY 56 0.0062
162 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 4 0.0060
163 STREPTOCOCCAL SEPSIS 7 0.0059
164 ARACHNOIDITIS 4 0.0058
165 FINGER DEFORMITY 28 0.0058
166 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 8 0.0057
167 AMNIOTIC CAVITY INFECTION 4 0.0055
168 SUBRETINAL FLUID 6 0.0055
169 FOREIGN BODY SENSATION IN EYES 35 0.0055
170 CHOROIDAL DETACHMENT 3 0.0054
171 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 5 0.0054
172 RETINAL DEGENERATION 7 0.0054
173 CONJUNCTIVAL HYPERAEMIA 19 0.0053
174 NAIL DISORDER 46 0.0053
175 INTRAOCULAR PRESSURE INCREASED 67 0.0052
176 HELICOBACTER INFECTION 53 0.0052
177 PSEUDOMONAL SEPSIS 9 0.0051
178 VITILIGO 12 0.0051
179 EMBOLIA CUTIS MEDICAMENTOSA 4 0.0050
180 BURSITIS 61 0.0050
181 LIVE BIRTH 42 0.0050
182 WOUND 140 0.0050
183 VISUAL ACUITY REDUCED 165 0.0050
184 GIANT CELL ARTERITIS 4 0.0048
185 HAND DEFORMITY 63 0.0048
186 CORNEAL PERFORATION 3 0.0048
187 CONJUNCTIVAL HAEMORRHAGE 18 0.0047
188 WOUND INFECTION 51 0.0047
189 CHORIORETINITIS 3 0.0047
190 JOINT RANGE OF MOTION DECREASED 62 0.0046
191 UTERINE PROLAPSE 5 0.0046
192 TONSILLITIS 24 0.0046
193 PILOERECTION 5 0.0046
194 DRY AGE-RELATED MACULAR DEGENERATION 5 0.0045
195 BLEPHARITIS 18 0.0045
196 DISLOCATION OF VERTEBRA 10 0.0044
197 CERUMEN IMPACTION 4 0.0044
198 INFUSION SITE REACTION 13 0.0043
199 PUPILLARY REFLEX IMPAIRED 8 0.0043
200 DERMATITIS EXFOLIATIVE GENERALISED 15 0.0043
201 CARDIOVASCULAR INSUFFICIENCY 7 0.0043
202 FUSARIUM INFECTION 3 0.0043
203 PORPHYRIA ACUTE 6 0.0042
204 PCO2 DECREASED 4 0.0041
205 EPIDERMAL NECROSIS 4 0.0041
206 CORNEAL DISORDER 9 0.0041
207 TYPE 2 DIABETES MELLITUS 137 0.0041
208 BLINDNESS UNILATERAL 57 0.0040
209 GRIP STRENGTH DECREASED 35 0.0040
210 CHLAMYDIAL INFECTION 3 0.0040
211 MACULOPATHY 14 0.0039
212 MACULAR HOLE 5 0.0037
213 AMAUROSIS FUGAX 4 0.0037
214 C-REACTIVE PROTEIN INCREASED 135 0.0037
215 ULCERATIVE KERATITIS 10 0.0036
216 RETINAL TEAR 9 0.0036
217 STAPHYLOCOCCAL SEPSIS 18 0.0036
218 KERATITIS 11 0.0036
219 SYSTEMIC LUPUS ERYTHEMATOSUS 128 0.0036
220 GLOSSODYNIA 80 0.0036
221 EYELID OEDEMA 41 0.0035
222 EYE PAIN 199 0.0035
223 FIBROMYALGIA 84 0.0035
224 DERMATITIS BULLOUS 25 0.0035
225 CATHETER SITE PRURITUS 3 0.0034
226 MULTIPLE USE OF SINGLE-USE PRODUCT 19 0.0034
227 CONJUNCTIVITIS ALLERGIC 5 0.0034
228 RETINAL VASCULITIS 4 0.0034
229 PSORIATIC ARTHROPATHY 136 0.0033
230 CATHETER MANAGEMENT 3 0.0033
231 STAPHYLOCOCCUS TEST POSITIVE 7 0.0033
232 PREMATURE RUPTURE OF MEMBRANES 8 0.0033
233 TOXIC SKIN ERUPTION 33 0.0033
234 ORAL MUCOSAL ERUPTION 5 0.0033
235 RETINAL ARTERY OCCLUSION 8 0.0032
236 PHOTOPSIA 20 0.0032
237 COR PULMONALE 3 0.0031
238 ANGLE CLOSURE GLAUCOMA 8 0.0031
239 NORMAL NEWBORN 17 0.0031
240 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 20 0.0031
241 PSYCHIATRIC DECOMPENSATION 6 0.0031
242 PROCEDURAL HAEMORRHAGE 12 0.0031
243 PURULENT DISCHARGE 13 0.0030
244 DERMATITIS CONTACT 34 0.0030
245 BENIGN BREAST NEOPLASM 3 0.0029
246 OSTEOLYSIS 6 0.0029
247 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 6 0.0029
248 OCULAR DISCOMFORT 32 0.0028
249 CARPAL TUNNEL DECOMPRESSION 3 0.0028
250 BURNS THIRD DEGREE 3 0.0028
251 NECROTISING FASCIITIS 10 0.0028
252 RETINAL DETACHMENT 26 0.0028
253 OBESITY 45 0.0028
254 UVEITIS 38 0.0028
255 X-RAY ABNORMAL 5 0.0028
256 ANAPHYLACTIC SHOCK 72 0.0028
257 CONTRAINDICATED PRODUCT ADMINISTERED 84 0.0028
258 EPILEPSY 84 0.0027
259 PRODUCT LABEL CONFUSION 16 0.0027
260 PARONYCHIA 12 0.0027
261 NORMOCYTIC ANAEMIA 4 0.0027
262 LIVER INJURY 66 0.0027
263 CATHETER SITE DISCHARGE 3 0.0027
264 CONJUNCTIVITIS 49 0.0026
265 ASTIGMATISM 4 0.0026
266 TASTE DISORDER 53 0.0026
267 POST PROCEDURAL COMPLICATION 49 0.0025
268 HYPERAEMIA 5 0.0025
269 IRRITABLE BOWEL SYNDROME 54 0.0025
270 SWOLLEN JOINT COUNT INCREASED 8 0.0025
271 GENITAL HAEMORRHAGE 32 0.0025
272 RASH VESICULAR 12 0.0025
273 DYSFUNCTIONAL UTERINE BLEEDING 3 0.0025
274 EYELID PAIN 5 0.0025
275 ANAPHYLACTOID REACTION 10 0.0024
276 PENIS DISORDER 6 0.0024
277 IMPAIRED SELF-CARE 5 0.0024
278 CHRONIC SINUSITIS 9 0.0024
279 STRIDOR 7 0.0024
280 IMPAIRED HEALING 78 0.0024
281 CHEMICAL BURN OF SKIN 6 0.0024
282 ULCER HAEMORRHAGE 16 0.0024
283 DIABETIC RETINOPATHY 8 0.0024
284 ADNEXA UTERI PAIN 3 0.0023
285 CATHETER SITE ERYTHEMA 5 0.0023
286 BLOOD CHLORIDE DECREASED 6 0.0023
287 HYPOALBUMINAEMIA 18 0.0023
288 CATHETER SITE PAIN 6 0.0023
289 PUPIL FIXED 4 0.0023
290 ORAL INFECTION 9 0.0023
291 ANGIONEUROTIC OEDEMA 6 0.0022
292 ANAESTHETIC COMPLICATION 6 0.0022
293 BLINDNESS 90 0.0022
294 BACK INJURY 24 0.0022
295 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 17 0.0022
296 BLINDNESS TRANSIENT 16 0.0022
297 WOUND SECRETION 8 0.0020
298 INFLAMMATION 103 0.0020
299 EYELID IRRITATION 5 0.0020
300 VASODILATATION 5 0.0020
301 EYE INJURY 6 0.0020
302 PATHOGEN RESISTANCE 18 0.0020
303 IRITIS 6 0.0020
304 EYE HAEMORRHAGE 26 0.0019
305 MOUTH ULCERATION 41 0.0019
306 EYE ALLERGY 3 0.0019
307 BACTERIAL VAGINOSIS 3 0.0019
308 EYE IRRITATION 110 0.0019
309 PERSONALITY DISORDER 5 0.0019
310 FEBRILE BONE MARROW APLASIA 8 0.0019
311 INFUSION RELATED REACTION 124 0.0019
312 POOR QUALITY DRUG ADMINISTERED 12 0.0019
313 TOXIC EPIDERMAL NECROLYSIS 28 0.0018
314 LYMPHOPENIA 26 0.0018
315 EYE DISCHARGE 19 0.0018
316 ASTHENOPIA 10 0.0018
317 BACTERIAL TEST POSITIVE 4 0.0018
318 THERAPEUTIC PRODUCT EFFECT DECREASED 80 0.0018
319 URINARY TRACT DISORDER 8 0.0018
320 CHRONIC GASTRITIS 4 0.0018
321 NIGHT SWEATS 57 0.0018
322 VASCULAR DEVICE INFECTION 8 0.0018
323 ENTERITIS INFECTIOUS 3 0.0018
324 BLISTER 99 0.0018
325 LACRIMATION INCREASED 53 0.0018
326 PUSTULAR PSORIASIS 6 0.0017
327 ADVERSE REACTION 23 0.0017
328 RHEUMATOID FACTOR POSITIVE 10 0.0017
329 BURNS SECOND DEGREE 3 0.0017
330 TYPE I HYPERSENSITIVITY 6 0.0017
331 HYPERURICAEMIA 7 0.0017
332 PHOTOPHOBIA 32 0.0017
333 OCULAR HYPERAEMIA 80 0.0017
334 MYOSITIS 15 0.0017
335 STOMATITIS 101 0.0017
336 PULSE ABNORMAL 4 0.0017
337 ANAPHYLACTIC REACTION 91 0.0016
338 MEDICAL DEVICE DISCOMFORT 5 0.0016
339 ABNORMAL SENSATION IN EYE 7 0.0016
340 SKIN INFECTION 18 0.0016
341 CATHETER SITE HAEMORRHAGE 4 0.0016
342 DERMATITIS EXFOLIATIVE 8 0.0016
343 GAIT INABILITY 53 0.0016
344 IRON DEFICIENCY 7 0.0016
345 CANDIDA INFECTION 26 0.0015
346 CONCOMITANT DISEASE PROGRESSION 3 0.0015
347 OSTEOARTHRITIS 65 0.0015
348 DEAFNESS NEUROSENSORY 5 0.0015
349 SUDDEN DEATH 16 0.0015
350 VAGINAL DISCHARGE 15 0.0015
351 PROCEDURAL PAIN 41 0.0015
352 SWELLING 138 0.0015
353 KIDNEY TRANSPLANT REJECTION 7 0.0015
354 WOUND COMPLICATION 5 0.0015
355 ORAL CANDIDIASIS 19 0.0014
356 UNDERDOSE 105 0.0014
357 STREPTOCOCCAL INFECTION 8 0.0014
358 FOETAL DISTRESS SYNDROME 3 0.0014
359 BONE EROSION 5 0.0014
360 TONGUE DISCOMFORT 6 0.0014
361 EMBEDDED DEVICE 14 0.0014
362 UTERINE HAEMORRHAGE 6 0.0014
363 GENERALISED ERYTHEMA 8 0.0014
364 DRUG-INDUCED LIVER INJURY 44 0.0014
365 BLOOD CHOLESTEROL INCREASED 65 0.0014
366 DISCOMFORT 85 0.0014
367 LOWER RESPIRATORY TRACT INFECTION 63 0.0014
368 ILL-DEFINED DISORDER 84 0.0014
369 CERVICAL DYSPLASIA 3 0.0014
370 SLEEP DISORDER 97 0.0014
371 RASH PUSTULAR 10 0.0014
372 METASTASES TO LYMPH NODES 9 0.0013
373 PAPILLOEDEMA 6 0.0013
374 COELIAC DISEASE 13 0.0013
375 DYSCHEZIA 4 0.0013
376 INJECTION SITE REACTION 90 0.0013
377 RASH MACULO-PAPULAR 29 0.0013
378 ERYTHEMA OF EYELID 7 0.0013
379 HAEMATURIA 44 0.0013
380 APPLICATION SITE REACTION 9 0.0013
381 RHEUMATOID ARTHRITIS 145 0.0013
382 SWELLING OF EYELID 8 0.0013
383 LUNG DISORDER 62 0.0013
384 SCIATICA 20 0.0013
385 ENTEROCOCCAL INFECTION 6 0.0012
386 DEVICE RELATED INFECTION 19 0.0012
387 GLOMERULONEPHRITIS 3 0.0012
388 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 87 0.0012
389 DERMAL CYST 3 0.0012
390 LUPUS-LIKE SYNDROME 11 0.0012
391 VISION BLURRED 164 0.0012
392 POSTOPERATIVE WOUND INFECTION 8 0.0012
393 LIP OEDEMA 5 0.0012
394 RED BLOOD CELL SEDIMENTATION RATE INCREASED 13 0.0012
395 CANCER PAIN 3 0.0012
396 ABSCESS LIMB 5 0.0012
397 MACULAR DEGENERATION 14 0.0012
398 TREATMENT FAILURE 97 0.0012
399 GASTROENTERITIS 17 0.0012
400 VISUAL IMPAIRMENT 144 0.0012
401 VARICOSE VEIN 6 0.0012
402 INTENTIONAL PRODUCT USE ISSUE 101 0.0012
403 COMPARTMENT SYNDROME 3 0.0011
404 WHEEZING 68 0.0011
405 EOSINOPHILIA 20 0.0011
406 MELANOCYTIC NAEVUS 5 0.0011
407 SKIN REACTION 16 0.0011
408 ARTHROPATHY 63 0.0011
409 RENAL FAILURE ACUTE 48 0.0011
410 THERMAL BURN 8 0.0011
411 VISUAL FIELD DEFECT 8 0.0011
412 SPONDYLITIS 4 0.0011
413 UTERINE LEIOMYOMA 8 0.0011
414 GASTROOESOPHAGEAL REFLUX DISEASE 87 0.0011
415 ROSACEA 5 0.0011
416 ERYTHEMA MULTIFORME 10 0.0011
417 ACUTE PULMONARY OEDEMA 6 0.0011
418 STAPHYLOCOCCAL INFECTION 35 0.0011
419 BREAST CANCER STAGE IV 3 0.0011
420 CATHETER SITE INFECTION 4 0.0011
421 SWOLLEN TONGUE 33 0.0011
422 SUBCUTANEOUS ABSCESS 5 0.0010
423 FINE MOTOR SKILL DYSFUNCTION 3 0.0010
424 MATERNAL EXPOSURE DURING PREGNANCY 92 0.0010
425 ABDOMINAL PAIN LOWER 26 0.0010
426 AUTOIMMUNE DISORDER 10 0.0010
427 LIVER FUNCTION TEST INCREASED 22 0.0010
428 CATARACT 61 0.0010
429 EYE SWELLING 38 0.0010
430 RENAL TUBULAR NECROSIS 10 0.0010
431 OEDEMA 55 0.0010
432 BLOOD CULTURE POSITIVE 3 0.0010
433 BONE MARROW DISORDER 3 0.0010
434 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 17 0.0010
435 PELVIC PAIN 18 0.0010
436 SEPTIC SHOCK 43 0.0010
437 POST PROCEDURAL INFECTION 8 0.0010
438 LARYNGEAL OEDEMA 6 0.0010
439 CONCOMITANT DISEASE AGGRAVATED 6 0.0010
440 SKIN NECROSIS 5 0.0010
441 LYMPHOCYTE COUNT DECREASED 17 0.0010
442 COMPLICATION OF DEVICE INSERTION 19 0.0010
443 EYE PRURITUS 32 0.0010
444 HYPOCALCAEMIA 18 0.0010
445 BLOOD LACTIC ACID INCREASED 5 0.0009
446 SKIN LESION 26 0.0009
447 DRUG INTOLERANCE 91 0.0009
448 CONFUSIONAL STATE 152 0.0009
449 PULMONARY FIBROSIS 18 0.0009
450 DRY MOUTH 76 0.0009
451 ANAL ABSCESS 5 0.0009
452 GINGIVITIS 5 0.0009
453 HORDEOLUM 4 0.0009
454 CHEILITIS 5 0.0009
455 HYPOGAMMAGLOBULINAEMIA 6 0.0009
456 APHTHOUS ULCER 7 0.0009
457 OVARIAN CYST 9 0.0009
458 RHINITIS ALLERGIC 4 0.0009
459 ILEUS PARALYTIC 4 0.0009
460 HYPERSENSITIVITY 166 0.0009
461 EYE INFECTION 10 0.0009
462 LOW BIRTH WEIGHT BABY 7 0.0009
463 GRANULOCYTOPENIA 5 0.0009
464 EXOSTOSIS 8 0.0009
465 DERMATITIS ALLERGIC 11 0.0009
466 ISCHAEMIA 4 0.0009
467 URTICARIA 145 0.0009
468 LOCALISED OEDEMA 4 0.0009
469 NEPHROGENIC ANAEMIA 4 0.0009
470 DEFAECATION URGENCY 6 0.0009
471 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
472 FIBRIN D DIMER INCREASED 3 0.0008
473 BLOOD PRESSURE INADEQUATELY CONTROLLED 5 0.0008
474 GANGRENE 5 0.0008
475 HYPOXIA 29 0.0008
476 MUSCULOSKELETAL PAIN 43 0.0008
477 GENERALISED OEDEMA 10 0.0008
478 HYPOKALAEMIA 37 0.0008
479 VULVOVAGINAL PRURITUS 4 0.0008
480 PATHOLOGICAL FRACTURE 4 0.0008
481 DYSLIPIDAEMIA 4 0.0008
482 PROCEDURAL COMPLICATION 6 0.0008
483 ASCITES 23 0.0008
484 MIGRAINE 74 0.0008
485 LOW DENSITY LIPOPROTEIN INCREASED 6 0.0008
486 FACE OEDEMA 13 0.0008
487 BRONCHOSPASM 11 0.0008
488 JOINT SWELLING 93 0.0008
489 ABDOMINAL DISCOMFORT 129 0.0008
490 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
491 CANDIDIASIS 3 0.0007
492 FUNGAL SKIN INFECTION 3 0.0007
493 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 19 0.0007
494 CLOSTRIDIUM DIFFICILE INFECTION 16 0.0007
495 ARTHRITIS BACTERIAL 3 0.0007
496 EYE MOVEMENT DISORDER 5 0.0007
497 ECCHYMOSIS 5 0.0007
498 LOWER LIMB FRACTURE 14 0.0007
499 SPINAL COMPRESSION FRACTURE 6 0.0007
500 HYPERKERATOSIS 4 0.0007
501 DERMATITIS 15 0.0007
502 RASH ERYTHEMATOUS 34 0.0007
503 PRODUCT USE IN UNAPPROVED INDICATION 176 0.0007
504 SKIN TOXICITY 4 0.0007
505 PREMATURE LABOUR 4 0.0007
506 SINUS TACHYCARDIA 10 0.0007
507 GENERAL PHYSICAL HEALTH DETERIORATION 81 0.0007
508 PSEUDOMONAS INFECTION 6 0.0007
509 METASTASES TO CENTRAL NERVOUS SYSTEM 9 0.0007
510 BACTERIAL INFECTION 13 0.0007
511 HEPATIC CIRRHOSIS 13 0.0007
512 URINE OUTPUT DECREASED 6 0.0007
513 HYPERTRIGLYCERIDAEMIA 4 0.0007
514 ORAL DISORDER 5 0.0007
515 MELAENA 15 0.0007
516 GINGIVAL SWELLING 3 0.0007
517 STEVENS-JOHNSON SYNDROME 15 0.0007
518 CATARACT OPERATION 4 0.0007
519 ODYNOPHAGIA 4 0.0007
520 RASH 289 0.0007
521 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
522 RASH GENERALISED 17 0.0007
523 DYSPAREUNIA 3 0.0007
524 FEBRILE NEUTROPENIA 43 0.0006
525 BLOOD SODIUM DECREASED 12 0.0006
526 DEVICE DEPLOYMENT ISSUE 8 0.0006
527 INJURY 44 0.0006
528 FAECAL INCONTINENCE 3 0.0006
529 PARAESTHESIA ORAL 9 0.0006
530 FISTULA 7 0.0006
531 RHINITIS 5 0.0006
532 MENORRHAGIA 12 0.0006
533 POLYURIA 5 0.0006
534 APPLICATION SITE BURN 3 0.0006
535 WALKING AID USER 4 0.0006
536 PRODUCT USE ISSUE 114 0.0006
537 ANEURYSM 3 0.0006
538 MENINGITIS 4 0.0006
539 DEVICE DISLOCATION 26 0.0006
540 HYPOAESTHESIA ORAL 9 0.0006
541 ERYSIPELAS 3 0.0006
542 CELLULITIS 30 0.0006
543 UTERINE PERFORATION 5 0.0006
544 DRUG RESISTANCE 15 0.0006
545 DIPLOPIA 15 0.0006
546 NOCTURIA 7 0.0006
547 MASS 8 0.0006
548 RASH MACULAR 20 0.0006
549 GLAUCOMA 11 0.0006
550 MUSCULOSKELETAL STIFFNESS 50 0.0006
551 OFF LABEL USE 496 0.0006
552 NEUTROPHIL COUNT DECREASED 23 0.0006
553 PHARYNGITIS 7 0.0006
554 ABSCESS 9 0.0006
555 EXPOSURE DURING PREGNANCY 35 0.0006
556 HYPOAESTHESIA 84 0.0006
557 WRONG DRUG ADMINISTERED 5 0.0006
558 BRUXISM 3 0.0006
559 BRAIN OEDEMA 7 0.0006
560 ALOPECIA 108 0.0005
561 SEPSIS 61 0.0005
562 MYDRIASIS 7 0.0005
563 DEAFNESS UNILATERAL 3 0.0005
564 RESPIRATORY DISTRESS 15 0.0005
565 HYPERTENSION 115 0.0005
566 GASTRIC ULCER HAEMORRHAGE 3 0.0005
567 NECK PAIN 30 0.0005
568 APPENDICITIS 5 0.0005
569 HYDRONEPHROSIS 4 0.0005
570 CIRCULATORY COLLAPSE 9 0.0005
571 GASTROINTESTINAL DISORDER 47 0.0005
572 RECALLED PRODUCT ADMINISTERED 5 0.0005
573 DRY EYE 26 0.0005
574 ANGIOEDEMA 23 0.0005
575 ATELECTASIS 5 0.0005
576 EYE DISORDER 17 0.0005
577 PRESCRIBED OVERDOSE 10 0.0005
578 CONGENITAL ANOMALY 4 0.0005
579 PRODUCT QUALITY ISSUE 70 0.0005
580 LUNG INFECTION 8 0.0005
581 DEVICE USE ISSUE 9 0.0005
582 EAR PAIN 10 0.0005
583 HEPATIC ENZYME INCREASED 35 0.0005
584 HAEMORRHAGIC STROKE 4 0.0005
585 MEMORY IMPAIRMENT 70 0.0005
586 DYSPEPSIA 50 0.0005
587 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
588 BACTERAEMIA 6 0.0005
589 BLOOD LACTATE DEHYDROGENASE INCREASED 8 0.0005
590 RESPIRATORY DISORDER 15 0.0005
591 PRESCRIBED UNDERDOSE 10 0.0005
592 APPLICATION SITE PAIN 11 0.0005
593 DISSEMINATED INTRAVASCULAR COAGULATION 7 0.0005
594 GAMMA-GLUTAMYLTRANSFERASE INCREASED 11 0.0005
595 MULTIPLE ORGAN DYSFUNCTION SYNDROME 14 0.0005
596 SCHIZOPHRENIA 6 0.0005
597 DERMATITIS ACNEIFORM 3 0.0005
598 DECUBITUS ULCER 4 0.0005
599 NEUTROPHIL COUNT INCREASED 5 0.0005
600 METASTASES TO BONE 8 0.0005
601 HYPERAESTHESIA 4 0.0005
602 SKIN EXFOLIATION 41 0.0005
603 OSTEONECROSIS OF JAW 12 0.0005
604 NASOPHARYNGITIS 89 0.0005
605 ILEUS 6 0.0005
606 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
607 NERVOUS SYSTEM DISORDER 15 0.0005
608 SHOCK 11 0.0005
609 ECZEMA 25 0.0005
610 MOBILITY DECREASED 34 0.0005
611 JOINT DISLOCATION 5 0.0005
612 DEPRESSION 107 0.0005
613 HEPATITIS 12 0.0005
614 SINUSITIS 48 0.0005
615 THERAPY NON-RESPONDER 21 0.0005
616 ANOREXIA 6 0.0005
617 ANURIA 4 0.0005
618 SKIN ULCER 12 0.0005
619 SKIN FISSURES 9 0.0005
620 PLATELET COUNT INCREASED 6 0.0005
621 LEUKOPENIA 23 0.0005
622 ERYTHEMA 94 0.0005
623 ASPERGILLUS INFECTION 3 0.0005
624 CARDIO-RESPIRATORY ARREST 19 0.0005
625 LUNG INFILTRATION 4 0.0005
626 PRESYNCOPE 11 0.0005
627 FOOT DEFORMITY 5 0.0005
628 INTESTINAL OBSTRUCTION 17 0.0005
629 DEVICE EXPULSION 29 0.0004
630 BLOOD BILIRUBIN INCREASED 12 0.0004
631 OSTEOMYELITIS 8 0.0004
632 ACUTE MYOCARDIAL INFARCTION 13 0.0004
633 CYSTITIS 14 0.0004
634 MYOCARDIAL ISCHAEMIA 5 0.0004
635 END STAGE RENAL DISEASE 8 0.0004
636 VAGINAL HAEMORRHAGE 19 0.0004
637 PERIPHERAL SWELLING 67 0.0004
638 DELIRIUM 15 0.0004
639 POST PROCEDURAL HAEMORRHAGE 5 0.0004
640 VASCULITIS 5 0.0004
641 PHARMACEUTICAL PRODUCT COMPLAINT 11 0.0004
642 ALANINE AMINOTRANSFERASE INCREASED 26 0.0004
643 ABDOMINAL PAIN UPPER 87 0.0004
644 DIVERTICULUM 3 0.0004
645 VIRAL INFECTION 14 0.0004
646 FEAR OF INJECTION 3 0.0004
647 JOINT STIFFNESS 11 0.0004
648 HYPERLIPIDAEMIA 5 0.0004
649 ALTERED STATE OF CONSCIOUSNESS 9 0.0004
650 INCORRECT PRODUCT ADMINISTRATION DURATION 9 0.0004
651 MEDICATION ERROR 23 0.0004
652 WRONG TECHNIQUE IN DRUG USAGE PROCESS 15 0.0004
653 ABDOMINAL PAIN 96 0.0004
654 ORAL HERPES 8 0.0004
655 HYPOTHYROIDISM 13 0.0004
656 BODY TEMPERATURE DECREASED 4 0.0004
657 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
658 HEPATIC FUNCTION ABNORMAL 15 0.0004
659 PYREXIA 139 0.0004
660 RASH PAPULAR 9 0.0004
661 CONDITION AGGRAVATED 122 0.0004
662 DECREASED APPETITE 92 0.0004
663 HEAD DISCOMFORT 7 0.0004
664 DRUG ERUPTION 7 0.0004
665 BONE MARROW FAILURE 8 0.0004
666 HYPONATRAEMIA 22 0.0004
667 URINARY RETENTION 13 0.0004
668 ROTATOR CUFF SYNDROME 5 0.0004
669 OSTEOPOROSIS 16 0.0004
670 HYPERBILIRUBINAEMIA 4 0.0004
671 HYPERGLYCAEMIA 14 0.0004
672 NODULE 5 0.0004
673 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
674 INJECTION SITE DISCOMFORT 4 0.0004
675 PLEURAL EFFUSION 23 0.0004
676 PAIN 231 0.0004
677 PLATELET COUNT DECREASED 40 0.0004
678 HYPOTENSION 75 0.0004
679 ABDOMINAL DISTENSION 39 0.0004
680 MUSCLE SPASMS 68 0.0004
681 RESPIRATORY FAILURE 27 0.0004
682 RASH PRURITIC 20 0.0004
683 PALLOR 10 0.0004
684 LYMPHADENOPATHY 13 0.0004
685 PHOTOSENSITIVITY REACTION 6 0.0004
686 ANAEMIA 69 0.0004
687 OEDEMA PERIPHERAL 44 0.0004
688 BREAST CANCER STAGE II 3 0.0004
689 TACHYCARDIA 32 0.0004
690 CARPAL TUNNEL SYNDROME 5 0.0004
691 PANCREATITIS ACUTE 8 0.0004
692 MITRAL VALVE INCOMPETENCE 4 0.0004
693 WHITE BLOOD CELL COUNT DECREASED 38 0.0004
694 MICTURITION URGENCY 4 0.0003
695 PREGNANCY 7 0.0003
696 IMPAIRED QUALITY OF LIFE 5 0.0003
697 MULTI-ORGAN FAILURE 6 0.0003
698 MYELODYSPLASTIC SYNDROME 5 0.0003
699 MUCOSAL INFLAMMATION 9 0.0003
700 APPLICATION SITE ERYTHEMA 9 0.0003
701 PARAESTHESIA 54 0.0003
702 AMENORRHOEA 6 0.0003
703 PRURITUS 131 0.0003
704 PNEUMONIA 110 0.0003
705 LIVER DISORDER 15 0.0003
706 BLOOD CREATININE INCREASED 22 0.0003
707 DISEASE RECURRENCE 16 0.0003
708 IMMUNODEFICIENCY 5 0.0003
709 GASTROINTESTINAL INFECTION 3 0.0003
710 ROAD TRAFFIC ACCIDENT 14 0.0003
711 FREQUENT BOWEL MOVEMENTS 9 0.0003
712 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 16 0.0003
713 PREMATURE BABY 10 0.0003
714 COMPLICATION OF DEVICE REMOVAL 6 0.0003
715 LEUKOCYTOSIS 6 0.0003
716 LOCALISED INFECTION 8 0.0003
717 WEIGHT INCREASED 74 0.0003
718 NO THERAPEUTIC RESPONSE 4 0.0003
719 HIP ARTHROPLASTY 5 0.0003
720 MUSCULAR WEAKNESS 37 0.0003
721 VOMITING 153 0.0003
722 CARDIOMEGALY 4 0.0003
723 BRONCHITIS 24 0.0003
724 HYPERCALCAEMIA 4 0.0003
725 CYST 4 0.0003
726 ASPARTATE AMINOTRANSFERASE INCREASED 17 0.0003
727 ARTERIOSCLEROSIS 3 0.0003
728 COLITIS 12 0.0003
729 NAUSEA 250 0.0003
730 OVERDOSE 68 0.0003
731 RHINORRHOEA 20 0.0003
732 HAEMATOMA 8 0.0003
733 TINNITUS 14 0.0003
734 SKIN DISCOLOURATION 14 0.0003
735 HAEMATOCRIT DECREASED 6 0.0003
736 OXYGEN SATURATION DECREASED 17 0.0003
737 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
738 DYSMENORRHOEA 4 0.0003
739 CONTUSION 29 0.0003
740 EAR INFECTION 8 0.0003
741 RESTLESSNESS 11 0.0003
742 CARDIAC FAILURE 24 0.0003
743 MENSTRUATION IRREGULAR 8 0.0003
744 BLOOD UREA INCREASED 5 0.0003
745 EYELID PTOSIS 3 0.0003
746 DRUG EXPOSURE DURING PREGNANCY 10 0.0003
747 DRUG TOXICITY 4 0.0003
748 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 16 0.0003
749 DYSPNOEA 165 0.0003
750 NEURALGIA 7 0.0003
751 ORAL DISCOMFORT 4 0.0003
752 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
753 LOCAL SWELLING 5 0.0003
754 BLOOD PRESSURE DECREASED 19 0.0003
755 PANCREATITIS 15 0.0003
756 ASTHMA 32 0.0003
757 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
758 METABOLIC ACIDOSIS 9 0.0003
759 UPPER RESPIRATORY TRACT INFECTION 13 0.0003
760 PNEUMONIA ASPIRATION 7 0.0003
761 ARTHRALGIA 115 0.0003
762 BIPOLAR DISORDER 3 0.0003
763 CHOLELITHIASIS 9 0.0003
764 BLOOD GLUCOSE FLUCTUATION 3 0.0003
765 CARDIOMYOPATHY 4 0.0003
766 FUNGAL INFECTION 9 0.0003
767 PANCYTOPENIA 15 0.0003
768 BRADYCARDIA 14 0.0003
769 ECONOMIC PROBLEM 4 0.0003
770 OSTEOPENIA 4 0.0003
771 ACUTE KIDNEY INJURY 40 0.0003
772 AMNESIA 17 0.0003
773 INSOMNIA 69 0.0003
774 FALL 86 0.0003
775 LIMB INJURY 7 0.0003
776 MALAISE 113 0.0003
777 ACUTE MYELOID LEUKAEMIA 4 0.0003
778 HYPERKALAEMIA 9 0.0003
779 ADVERSE DRUG REACTION 23 0.0003
780 RECTAL HAEMORRHAGE 11 0.0003
781 CHILLS 30 0.0003
782 CYANOSIS 4 0.0003
783 RESPIRATORY ARREST 7 0.0003
784 DISABILITY 5 0.0003
785 CHOLECYSTITIS 3 0.0003
786 ULCER 4 0.0003
787 PRODUCTIVE COUGH 12 0.0003
788 INFECTION 36 0.0002
789 CHEST PAIN 46 0.0002
790 INTERSTITIAL LUNG DISEASE 12 0.0002
791 DRUG INEFFECTIVE 326 0.0002
792 FEEDING DISORDER 5 0.0002
793 PAIN IN EXTREMITY 72 0.0002
794 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
795 CARDIAC ARREST 20 0.0002
796 EPISTAXIS 18 0.0002
797 LIP SWELLING 8 0.0002
798 SKIN DISORDER 8 0.0002
799 ADVERSE EVENT 22 0.0002
800 KNEE ARTHROPLASTY 5 0.0002
801 URINARY INCONTINENCE 7 0.0002
802 DIABETES MELLITUS 18 0.0002
803 HEMIPARESIS 4 0.0002
804 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 4 0.0002
805 EATING DISORDER 5 0.0002
806 METRORRHAGIA 4 0.0002
807 RETCHING 5 0.0002
808 FOETAL EXPOSURE DURING PREGNANCY 19 0.0002
809 SCAR 4 0.0002
810 HYPOACUSIS 10 0.0002
811 HEPATIC FAILURE 7 0.0002
812 DYSPHAGIA 22 0.0002
813 ORTHOSTATIC HYPOTENSION 4 0.0002
814 DEAFNESS 6 0.0002
815 METASTASES TO LIVER 4 0.0002
816 HERPES ZOSTER 13 0.0002
817 DIARRHOEA 146 0.0002
818 HEADACHE 141 0.0002
819 CONSTIPATION 49 0.0002
820 GOUT 4 0.0002
821 DIZZINESS 111 0.0002
822 DYSPHONIA 13 0.0002
823 PNEUMONITIS 6 0.0002
824 RENAL FAILURE 29 0.0002
825 DYSURIA 8 0.0002
826 ASTHENIA 81 0.0002
827 VERTIGO 13 0.0002
828 DEVICE OCCLUSION 3 0.0002
829 HALLUCINATION 16 0.0002
830 FEELING HOT 13 0.0002
831 CHRONIC KIDNEY DISEASE 16 0.0002
832 PROTEINURIA 4 0.0002
833 MUSCULOSKELETAL DISORDER 4 0.0002
834 CARDIOGENIC SHOCK 3 0.0002
835 BLOOD PRESSURE FLUCTUATION 5 0.0002
836 ACUTE RESPIRATORY FAILURE 4 0.0002
837 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
838 ANOSMIA 3 0.0002
839 CEREBROVASCULAR ACCIDENT 35 0.0002
840 OROPHARYNGEAL PAIN 19 0.0002
841 URINARY TRACT INFECTION 34 0.0002
842 THROMBOCYTOPENIA 22 0.0002
843 SKIN IRRITATION 9 0.0002
844 GAIT DISTURBANCE 37 0.0002
845 PERITONITIS 4 0.0002
846 SEDATION 5 0.0002
847 SYNCOPE 19 0.0002
848 DEVICE ISSUE 17 0.0002
849 COMA 9 0.0002
850 FATIGUE 147 0.0002
851 CARDIAC FAILURE CONGESTIVE 15 0.0002
852 JAUNDICE 5 0.0002
853 HAEMOGLOBIN DECREASED 19 0.0002
854 BLOOD POTASSIUM INCREASED 3 0.0002
855 SWELLING FACE 12 0.0002
856 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
857 BACK PAIN 42 0.0002
858 CYTOMEGALOVIRUS INFECTION 3 0.0002
859 COAGULOPATHY 3 0.0002
860 MENTAL STATUS CHANGES 5 0.0002
861 THROAT IRRITATION 8 0.0002
862 COUGH 50 0.0002
863 ARTHRITIS 14 0.0002
864 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
865 NEUTROPENIA 24 0.0002
866 MALIGNANT NEOPLASM PROGRESSION 18 0.0002
867 RED BLOOD CELL COUNT DECREASED 5 0.0002
868 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
869 LOSS OF CONSCIOUSNESS 22 0.0002
870 NASAL CONGESTION 10 0.0002
871 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
872 PSYCHOTIC DISORDER 5 0.0002
873 APHASIA 5 0.0002
874 CRYING 6 0.0002
875 BONE DISORDER 3 0.0002
876 TREATMENT NONCOMPLIANCE 9 0.0002
877 CEREBRAL INFARCTION 4 0.0002
878 BLOOD PRESSURE INCREASED 25 0.0002
879 HAEMORRHAGE 17 0.0002
880 AGRANULOCYTOSIS 3 0.0002
881 AGEUSIA 4 0.0002
882 HEAD INJURY 5 0.0002
883 HAEMATEMESIS 4 0.0002
884 WEIGHT DECREASED 44 0.0002
885 FEELING JITTERY 3 0.0002
886 FLUID RETENTION 8 0.0002
887 BURNING SENSATION 11 0.0002
888 HIP FRACTURE 5 0.0002
889 HYPERHIDROSIS 20 0.0002
890 OSTEONECROSIS 5 0.0002
891 GASTRITIS 4 0.0002
892 DEPRESSED MOOD 8 0.0002
893 DEVICE DIFFICULT TO USE 10 0.0002
894 BLOOD PRESSURE ABNORMAL 3 0.0002
895 AGITATION 11 0.0001
896 THROAT TIGHTNESS 4 0.0001
897 UNEVALUABLE EVENT 11 0.0001
898 NIGHTMARE 5 0.0001
899 FEELING COLD 4 0.0001
900 BLOOD GLUCOSE INCREASED 27 0.0001
901 DEMENTIA 4 0.0001
902 PAIN IN JAW 4 0.0001
903 ANGINA PECTORIS 4 0.0001
904 BALANCE DISORDER 12 0.0001
905 INTENTIONAL PRODUCT MISUSE 12 0.0001
906 LABORATORY TEST ABNORMAL 4 0.0001
907 PULMONARY OEDEMA 6 0.0001
908 ATRIAL FIBRILLATION 13 0.0001
909 CHROMATURIA 3 0.0001
910 APPLICATION SITE PRURITUS 3 0.0001
911 CORONARY ARTERY DISEASE 4 0.0001
912 CHEST DISCOMFORT 13 0.0001
913 ANXIETY 36 0.0001
914 MYALGIA 21 0.0001
915 DEVICE BREAKAGE 5 0.0001
916 DYSKINESIA 5 0.0001
917 LUNG NEOPLASM MALIGNANT 5 0.0001
918 NO ADVERSE EVENT 22 0.0001
919 SEIZURE 14 0.0001
920 RHABDOMYOLYSIS 5 0.0001
921 DISEASE PROGRESSION 14 0.0001
922 HOSPITALISATION 18 0.0001
923 THERAPEUTIC RESPONSE DECREASED 7 0.0001
924 PSORIASIS 15 0.0001
925 SOMNOLENCE 23 0.0001
926 ANHEDONIA 3 0.0001
927 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 20 0.0001
928 ABNORMAL DREAMS 3 0.0001
929 FLUSHING 11 0.0001
930 RENAL IMPAIRMENT 9 0.0001
931 DYSARTHRIA 4 0.0001
932 HOT FLUSH 8 0.0001
933 DEHYDRATION 14 0.0001
934 HEART RATE INCREASED 10 0.0001
935 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
936 MYOCARDIAL INFARCTION 17 0.0001
937 FEMUR FRACTURE 3 0.0001
938 FEELING ABNORMAL 23 0.0001
939 NERVOUSNESS 5 0.0001
940 DRUG EFFECT DECREASED 5 0.0001
941 MENTAL DISORDER 4 0.0001
942 COLITIS ULCERATIVE 4 0.0001
943 FLATULENCE 5 0.0001
944 GASTRIC DISORDER 3 0.0001
945 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
946 DEATH 75 0.0001
947 RENAL DISORDER 4 0.0001
948 CARDIAC DISORDER 8 0.0001
949 PALPITATIONS 10 0.0001
950 BONE PAIN 5 0.0001
951 SURGERY 5 0.0001
952 ARRHYTHMIA 4 0.0001
953 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 17 0.0001
954 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
955 BLOOD GLUCOSE DECREASED 4 0.0001
956 IRRITABILITY 5 0.0001
957 ACCIDENTAL OVERDOSE 3 0.0001
958 INFLUENZA 9 0.0001
959 INJECTION SITE ERYTHEMA 10 0.0001
960 DYSPNOEA EXERTIONAL 3 0.0001
961 ACNE 6 0.0001
962 ILLNESS 8 0.0001
963 DEEP VEIN THROMBOSIS 5 0.0001
964 SUICIDAL IDEATION 7 0.0001
965 SPEECH DISORDER 4 0.0001
966 DISORIENTATION 3 0.0001
967 DRY SKIN 10 0.0001
968 THROMBOSIS 6 0.0001
969 EMOTIONAL DISTRESS 9 0.0001
970 DISTURBANCE IN ATTENTION 4 0.0001
971 TREMOR 12 0.0001
972 INJECTION SITE PAIN 22 0.0001
973 DEVICE LEAKAGE 3 0.0001
974 TOXICITY TO VARIOUS AGENTS 11 0.0001
975 COGNITIVE DISORDER 3 0.0001
976 COVID-19 11 0.0001
977 PROSTATE CANCER 5 0.0001
978 PRODUCT DOSE OMISSION ISSUE 18 0.0001
979 INFLUENZA LIKE ILLNESS 5 0.0001
980 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
981 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
982 INCORRECT DOSE ADMINISTERED 13 0.0001
983 DERMATITIS ATOPIC 3 0.0001
984 PULMONARY EMBOLISM 5 0.0001
985 INJECTION SITE SWELLING 4 0.0001
986 DRUG DEPENDENCE 8 0.0000
987 PRODUCT STORAGE ERROR 4 0.0000
988 BREAST CANCER 4 0.0000
989 DEVICE MALFUNCTION 3 0.0000
990 NEUROPATHY PERIPHERAL 4 0.0000
991 DYSGEUSIA 3 0.0000
992 DRUG INTERACTION 6 0.0000
993 DRUG DOSE OMISSION 6 0.0000